Deafness: Malaria as a forgotten cause

Annals of Tropical Paediatrics

Volumn 31, Issue 1, 2011, Pages 1-10

  Zhao, S Z ^a   Mackenzie, I J ^a  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEETHER; ARTEMETHER; CHLOROQUINE; QUININE;

ARTICLE; AUDIOMETER; AUDIOMETRY; BRAIN MALARIA; EVOKED BRAIN STEM AUDITORY RESPONSE; HEARING IMPAIRMENT; HEARING LOSS; HUMAN; MALARIA; MALARIA FALCIPARUM; NEUROLOGIC DISEASE; OTOTOXICITY; PERCEPTION DEAFNESS; PLASMODIUM FALCIPARUM; PREVALENCE; RETROSPECTIVE STUDY; SYSTEMATIC REVIEW; TYMPANOMETRY;

ANTIMALARIALS; CHILD; DEAFNESS; HUMANS; MALARIA;

EID: 79551658509     PISSN: 02724936     EISSN: 14653281     Source Type: Journal    
DOI: 10.1179/146532811X12925735813724     Document Type: Article

References (30)

1. World HealthOrganization. Severe falciparummalaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg 2000; 94:1-90.
2. Idro R, Jenkins NE, Newton CR. Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol 2005; 4:827-40. (Pubitemid 41619438)
3. Holborow C, Martinson F, Anger N. A study of deafness in West Africa. Int J Pediatr Otorhinolaryngol 1982; 4:107-32.
4. Aithal V, Gupta AC, Vele D. Hearing loss in Papua New Guinea: a study of outpatients attending Port Moresby General Hospital. PNG Med J 1995; 38:36-44.
5. McPherson B, Holborow CA. A study of deafness in West Africa: the Gambian Hearing Health Project. Int J Pediatr Otorhinolaryngol 1985; 10:115-35. (Pubitemid 16212631)
6. Brobby GW. Causes of congenital and acquired total sensorineural hearing loss in Ghanaian children. Trop Doct 1988; 18:30-2.
7. Dunmade AD, Segun-Busari S, Olajide TG, Ologe FE. Profound bilateral sensorineural hearing loss in Nigerian children: any shift in etiology? J Deaf Stud Deaf Educ 2007; 12:112-18.
8. Sanohko A, Dareys JP, Charreau M. [Prolonged encephalitic condition and malarial pernicious attack]. Bull Soc Med Afr Noire Lang Fr 1968; 13:662-9.
9. Neequaye J, Ofori-Adjei E, Ofori-Adjei D, Renner L. Comparative trial of oral versus intramuscular chloroquine in children with cerebral malaria. Trans R Soc Trop Med Hyg 1991; 85:718-22.
10. Bondi FS. The incidence and outcome of neurological abnormalities in childhood cerebral malaria: a long-term follow-up of 62 survivors. Trans R Soc Trop Med Hyg 1992; 86:17-19.
11. Murphy S, English M, Waruiru C, et al. An open randomized trial of artemether versus quinine in the treatment of cerebral malaria in African children. Trans R Soc Trop Med Hyg 1996; 90:298-301.
12. Sowunmi A. Clinical study of cerebral malaria in African children. Afr J Med Med Sci 1997; 26:9-11.
13. Meremikwu MM, Asindi AA, Ezedinachi E. The pattern of neurological sequelae of childhood cerebral malaria among survivors in Calabar, Nigeria. Cent Afr J Med 1997; 43:231-4. (Pubitemid 128523481)
14. van Hensbroek MB, Palmer A, Jaffar S, Schneider G, Kwiatkowski D. Residual neurologic sequelae after childhood cerebralmalaria. J Pediatr 1997; 131:125-9.
15. Olumese PE, Gbadegesin RA, Adeyemo AA, Brown B, Walker A. Neurological features of cerebral malaria in Nigerian children. Ann Trop Paediatr 1999; 19:321-5.
16. Thuma PE, Bhat GJ, Mabeza GF, et al. A randomized controlled trial of artemotil (beta-artemether) in Zambian children with cerebral malaria. Am J Trop Med Hyg 2000; 62:524-9.
17. Chiabi A, Tchokoteu PF, Toupouri A, Mbeng TB, Wefuan J. The clinical spectrum of severe malaria in children in the east provincial hospital of Bertoua, Cameroon. Bull Soc Pathol Exot 2004; 97:239-43.
18. Idro R, Karamagi C, Tumwine J. Immediate outcome and prognostic factors for cerebral malaria among children admitted to Mulago Hospital, Uganda. Ann Trop Paediatr 2004; 24:17-24. (Pubitemid 38379731)
19. Idro R, Otieno G, White S, et al. Decorticate, decerebrate and opisthotonic posturing and seizures in Kenyan children with cerebral malaria. Malar J 2005; 4:57.
20. Idro R, Ndiritu M, Ogutu B, et al. Burden, features, and outcome of neurological involvement in acute falciparum malaria in Kenyan children. JAMA 2007; 297:2232-40.
21. John CC, Panoskaltsis-Mortari A, Opoka RO, et al. Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria. Am J Trop Med Hyg 2008; 78:198-205.
22. Bondi FS. Childhood coma in Ibadan. Relationship to socio-economic factors. Trop Geogr Med 1991; 43:288-92.
23. Carter JA, Lees JA, Gona JK, et al. Severe falciparum malaria and acquired childhood language disorder. Dev Med Child Neurol 2006; 48:51-7.
24. Carrara VI, Phyo AP, Nwee P, et al. Auditory assessment of patients with acute uncomplicated Plasmodium falciparum malaria treated with three-day mefloquine-artesunate on the north-western border of Thailand. Malar J 2008; 7:233.
25. Gurkov R, Eshetu T, Miranda IB, et al. Ototoxicity of artemether/lumefantrine in the treatment of falciparum malaria: a randomized trial. Malar J 2008; 7:179.
26. Tange RA, Dreschler WA, Claessen FA, Perenboom RM. Ototoxic reactions of quinine in healthy persons and patients with Plasmodium falciparum infection. Auris Nasus Larynx 1997; 24:131-6.
27. McCall MB, Beynon AJ, Mylanus EA, van der Ven AJ, Sauerwein RW. No hearing loss associated with the use of artemether-lumefantrine to treat experimental human malaria. Trans R Soc Trop Med Hyg 2006; 100:1098-104.
28. Toovey S, Jamieson A. Audiometric changes associated with the treatment of uncomplicated falciparum malaria with co-artemether. Trans R Soc Trop Med Hyg 2004; 98:261-7; discussion 8-9.
29. Hoistad DL, Hain TC. Central hearing loss with a bilateral inferior colliculus lesion. Audiol Neurootol 2003; 8:111-13.
30. Mendez MF, Geehan Jr GR. Cortical auditory disorders: clinical and psychoacoustic features. J Neurol Neurosurg Psychiatry 1988; 51:1-9.